How Could In Vitro Antiviral Activity Be Applied to Optimize the Dosing Regimens of Candidates for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)?

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical infectious diseases 2021-07, Vol.73 (2), p.352-353
Hauptverfasser:	Jia, Ranran, Wang, Hongyun
Format:	Artikel
Sprache:	eng
Schlagworte:	Correspondence
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	353
container_issue	2
container_start_page	352
container_title	Clinical infectious diseases
container_volume	73
creator	Jia, Ranran Wang, Hongyun
description
doi_str_mv	10.1093/cid/ciaa1325
format	Article
fullrecord	<record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7717149</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/cid/ciaa1325</oup_id><sourcerecordid>2465438684</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421t-f84448d505c451ef721357b45395adc03ae19bb766ebf07afe38bde65337a4533</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhSNERX9gxwN4R5EItWM7cTagEH5aqVKlTunWcuybqVESB9sZNH0r3hAP0yJ1w8Lylc7nc498suw1we8JrumZtiYdpQgt-LPsiHBa5SWvyfM0Yy5yJqg4zI5D-IExIQLzF9khpQVjXNRH2e9z9wu1bhkMupjQrY3eoWaKdmO9GlCjd1Pcok-AmnkeLBgUHbqaox3tPaB4B-izC3Zao2tY2xGmgFyPWjUZa1SEgHrn_1I3HlRMetzpK9iAT456iZAehjkti85v0Wo7Ge9GSIm8m1QKsQRUoNNVc73KW3ebF28_vswOejUEePVwn2Tfv365ac_zy6tvF21zmWtWkJj3gjEmDMdcM06grwpCedUxTmuujMZUAam7ripL6HpcqR6o6AyUnNJKJYqeZB_2vvPSjWB0yp6-RM7ejspvpVNWPlUmeyfXbiOrilSE1cng9MHAu58LhChHGzQMg5rALUEWrOSMilKwhL7bo9q7EDz0_9YQLHcty9SyfGw54W_2uFvm_5N_AFa4qZI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2465438684</pqid></control><display><type>article</type><title>How Could In Vitro Antiviral Activity Be Applied to Optimize the Dosing Regimens of Candidates for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)?</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Jia, Ranran ; Wang, Hongyun</creator><creatorcontrib>Jia, Ranran ; Wang, Hongyun</creatorcontrib><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1093/cid/ciaa1325</identifier><identifier>PMID: 33244589</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Correspondence</subject><ispartof>Clinical infectious diseases, 2021-07, Vol.73 (2), p.352-353</ispartof><rights>The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2020</rights><rights>The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c421t-f84448d505c451ef721357b45395adc03ae19bb766ebf07afe38bde65337a4533</citedby><cites>FETCH-LOGICAL-c421t-f84448d505c451ef721357b45395adc03ae19bb766ebf07afe38bde65337a4533</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,1583,27923,27924</link.rule.ids></links><search><creatorcontrib>Jia, Ranran</creatorcontrib><creatorcontrib>Wang, Hongyun</creatorcontrib><title>How Could In Vitro Antiviral Activity Be Applied to Optimize the Dosing Regimens of Candidates for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)?</title><title>Clinical infectious diseases</title><subject>Correspondence</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kc1u1DAUhSNERX9gxwN4R5EItWM7cTagEH5aqVKlTunWcuybqVESB9sZNH0r3hAP0yJ1w8Lylc7nc498suw1we8JrumZtiYdpQgt-LPsiHBa5SWvyfM0Yy5yJqg4zI5D-IExIQLzF9khpQVjXNRH2e9z9wu1bhkMupjQrY3eoWaKdmO9GlCjd1Pcok-AmnkeLBgUHbqaox3tPaB4B-izC3Zao2tY2xGmgFyPWjUZa1SEgHrn_1I3HlRMetzpK9iAT456iZAehjkti85v0Wo7Ge9GSIm8m1QKsQRUoNNVc73KW3ebF28_vswOejUEePVwn2Tfv365ac_zy6tvF21zmWtWkJj3gjEmDMdcM06grwpCedUxTmuujMZUAam7ripL6HpcqR6o6AyUnNJKJYqeZB_2vvPSjWB0yp6-RM7ejspvpVNWPlUmeyfXbiOrilSE1cng9MHAu58LhChHGzQMg5rALUEWrOSMilKwhL7bo9q7EDz0_9YQLHcty9SyfGw54W_2uFvm_5N_AFa4qZI</recordid><startdate>20210715</startdate><enddate>20210715</enddate><creator>Jia, Ranran</creator><creator>Wang, Hongyun</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210715</creationdate><title>How Could In Vitro Antiviral Activity Be Applied to Optimize the Dosing Regimens of Candidates for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)?</title><author>Jia, Ranran ; Wang, Hongyun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421t-f84448d505c451ef721357b45395adc03ae19bb766ebf07afe38bde65337a4533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Correspondence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jia, Ranran</creatorcontrib><creatorcontrib>Wang, Hongyun</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jia, Ranran</au><au>Wang, Hongyun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>How Could In Vitro Antiviral Activity Be Applied to Optimize the Dosing Regimens of Candidates for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)?</atitle><jtitle>Clinical infectious diseases</jtitle><date>2021-07-15</date><risdate>2021</risdate><volume>73</volume><issue>2</issue><spage>352</spage><epage>353</epage><pages>352-353</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><cop>US</cop><pub>Oxford University Press</pub><pmid>33244589</pmid><doi>10.1093/cid/ciaa1325</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 1058-4838
ispartof	Clinical infectious diseases, 2021-07, Vol.73 (2), p.352-353
issn	1058-4838 1537-6591
language	eng
recordid	cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7717149
source	Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection
subjects	Correspondence
title	How Could In Vitro Antiviral Activity Be Applied to Optimize the Dosing Regimens of Candidates for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)?
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T02%3A54%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=How%20Could%20In%20Vitro%20Antiviral%20Activity%20Be%20Applied%20to%20Optimize%20the%20Dosing%20Regimens%20of%20Candidates%20for%20the%20Treatment%20of%20Severe%20Acute%20Respiratory%20Syndrome%20Coronavirus%202%20(SARS-CoV-2)?&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Jia,%20Ranran&rft.date=2021-07-15&rft.volume=73&rft.issue=2&rft.spage=352&rft.epage=353&rft.pages=352-353&rft.issn=1058-4838&rft.eissn=1537-6591&rft_id=info:doi/10.1093/cid/ciaa1325&rft_dat=%3Cproquest_pubme%3E2465438684%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2465438684&rft_id=info:pmid/33244589&rft_oup_id=10.1093/cid/ciaa1325&rfr_iscdi=true